Clinical trial
The Evaluation of the Effect of Wharton's Jelly Mesenchymal Stem Cells (WJMSCs) on the Immune System of Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT04651855 is registered in ClinicalTrials.gov with Polski Bank Komorek Macierzystych JSC (PBKM) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Evaluation of the Effect of Wharton's Jelly Mesenchymal Stem Cells (WJMSCs) on the Immune System of Patients With Amyotrophic Lateral Sclerosis (ALS)
- Lead sponsor
- Polski Bank Komorek Macierzystych JSC (PBKM)
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- December 2, 2020
- Completion date
- April 30, 2023
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.